Clinical trial Recruiting at 1 site Interventional Ages 60 to 85

Comparing domestic and imported hearing aids for age-related hearing loss

Official title: A Non-Inferiority, Single-Blind, Randomized Controlled Trial Comparing the Efficacy of Domestic Versus Imported Hearing Aids in Patients With Moderate to Severe and Severe Age-Related Hearing Loss

Run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06882889 · Data updated 2026-11-12

This study is testing whether hearing aids made in the U.S. work better than imported ones for older adults with age-related hearing loss.

More Age-related Hearing Loss trials

Quick facts

Study typeInterventional
Ages60 Years to 85 Years
SexAll
Enrollment80 (estimated)
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedOctober 24, 2024
Main results expectedAugust 30, 2025
Study endsDecember 31, 2025
Registry record updatedAugust 13, 2025
Trial IDNCT06882889 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese individuals aged 60 to 85 with moderate to severe age-related sensorineural hearing loss.

Probably not a fit

Patients with noise-induced, hereditary, or drug-induced hearing loss, or those unable to use hearing aids will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of domestic hearing aids from the Bigsound brand with imported hearing aids from the Phonak brand in patients aged 60 to 85 with moderate to severe age-related hearing loss. Eighty participants will be randomly assigned to either group and will undergo a 30-minute trial with their respective hearing aids. Hearing improvements will be measured using Pure Tone Average (PTA) and Speech Recognition Threshold (SRT) before and after the trial, and a cost-effectiveness analysis will be conducted based on the market prices and hearing improvements. Additionally, patient-reported outcomes will be assessed using standardized questionnaires.

Why it matters

Potential benefit: If successful, this study could help patients make informed choices about hearing aids based on their effectiveness and cost.

How similar studies have gone: Previous studies have shown varying results in comparing different hearing aid brands, but this specific comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 60 years and ≤ 85 years;
2. Diagnosed with age-related hearing Loss, which is characterized by bilateral, symmetrical, and gradually progressive hearing loss primarily affecting high frequencies, along with a decline in speech recognition ability, as referenced in the "Expert Consensus on Diagnosis and Intervention of Age-Related Hearing Loss" (2019 edition);
3. Age-related hearing Loss is of moderate to severe or severe sensorineural hearing loss, with moderate to severe defined as 50 to \<65 dB HL, and severe defined as 65 to \<80 dB HL;
4. Chinese nationality, able to complete all assessments in the Chinese language;
5. Right-handed;
6. No significant neurological diseases, severe systemic diseases, family history of genetic disorders, or major psychiatric conditions;

Exclusion Criteria:

1. Exclusion of noise-induced hearing loss, hereditary hearing loss, drug-induced hearing loss, etc.;
2. Inability to use hearing aids ;
3. Presence of dementia, Parkinson's disease, or other neurodegenerative diseases that may affect study compliance;
4. History of cerebrovascular accidents, stroke, epilepsy, or other central nervous system disorders;
5. Other conditions deemed by the investigator to be exclusionary.

Where it's running

  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.